Global Hemostats Market, Forecast Till 2025

  • Category : Healthcare and Pharma
  • |
  • ID : 863467
  • |
  • Date : March 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Hemostats Market was valued at USD XX million in 2017, and is expected to grow at a CAGR of XX% by 2025. Increasing incidence of sports-related injuries and spinal ailments are the major factors driving the growth of market.

The global Hemostats market is driven by increasing incidence of various diseases and increase in concern & awareness about health. Also factors, such as increase in the number of surgeries, and rise in the number of hospitals and surgical centers, is expected to increase the demand for Hemostats market.

Factors, such as advancements in minimally invasive surgical procedures will reduce the use of surgical hemostat can restrain the market growth.

The advancements in technology along with an increase in funding in R&D, will offer lucrative opportunities.

Based on Application, the Hemostats market is segmented into Cardiovascular surgery, General surgery, Gynecological surgery, Reconstructive surgery, Neurological surgery, Orthopedic surgery, and Other surgeries.

Based on Product Types, the Hemostats market is segmented into Gelatin Based, Combination Hemostats, Cellulose Based, Oxidized Regenerated, Collagen Based, and Others.

Regionally, North America was the largest revenue generator in the Hemostats market in 2017, because of high investments in research and development activities to investigate the applications of Hemostats market.

Some of the key players operating in this market include Johnson & Johnson, Marine Polymer Technologies, Inc., CryoLife, Inc., C. R. Bard, Inc., Baxter, Pfizer Inc., Integra Lifesciences Holdings Corporation, B Braun Melsungen AG, and Vascular Solutions, Inc., among others.

Key Benefits of the Report:
* Global, Regional, Country, Application, and Product Types Market Size and Forecast from 2014-2025
* Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
* Identification of key companies that can influence this market on a global and regional scale
* Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
* Detailed insights on emerging regions, Application& Product Types, and competitive landscape with qualitative and quantitative information and facts

Target Audience:
* Hemostats providers
* Traders, Importer and Exporter
* Raw material suppliers and distributors
* Research and consulting firms
* Government and research organizations
* Associations and industry bodies

Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics, capacity Product Types, spending were taken into consideration.

We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.
The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:
* Original Manufacturer,
* Application Supplier,
* Distributors,
* Government Body & Associations, and
* Research Institute

TABLE OF CONTENT

EXECUTIVE SUMMARY

1. METHODOLOGY AND MARKET SCOPE
1.1. Research Methodology
1.2. Research Scope & Assumptions

2. GLOBAL HEMOSTATS MARKET — INDUSTRY OUTLOOK
2.1. Market Segmentation and Scope
2.2. Market Size & Growth Prospects
2.3. Hemostats Market — Value Chain / Supply Chain Analysis
2.3.1. Company Landscape
2.4. Hemostats Market — Market Dynamics
2.4.1. Market Driver
2.4.2. Market Restraints
2.4.3. Market Challenges
2.5. Hemostats Market Company Market Share, 2017
2.6. Hemostats Market — Porter\'s Five Forces Analysis
2.7. Hemostats Market — Pestel Analysis

3. GLOBAL HEMOSTATS MARKET PRODUCT OUTLOOK
3.1. Hemostats Market Share by Product Types, 2017 & 2025
3.2. Gelatin Based
3.3. Combination Hemostats
3.4. Cellulose Based
3.5. Oxidized Regenerated
3.6. Collagen Based
3.7. Others

4. GLOBAL HEMOSTATS MARKET APPLICATION OUTLOOK
4.1. Hemostats Market Share By Application, 2017 & 2025
4.2. Cardiovascular surgery
4.3. General surgery
4.4. Gynecological surgery
4.5. Reconstructive surgery
4.6. Neurological surgery
4.7. Orthopedic surgery
4.8. Other surgeries

5. GLOBAL HEMOSTATS MARKET REGIONAL OUTLOOK
5.1. Hemostats Market Share by Region, 2017 & 2025
5.2. North America
5.2.1. North America Hemostats Market, 2014 - 2025
5.2.2. North America Hemostats Market, By Product Types, 2014 - 2025
5.2.3. North America Hemostats Market, By Application, 2014 - 2025
5.2.4. U.S.
5.2.4.1. U.S. Hemostats Market, By Product Types, 2014 - 2025
5.2.4.2. U.S. Hemostats Market, By Application, 2014 - 2025
5.2.5. Canada
5.2.5.1. Canada Hemostats Market, By Product Types, 2014 - 2025
5.2.5.2. Canada Hemostats Market, By Application, 2014 - 2025
5.3. Europe
5.3.1. Europe Hemostats Market, 2014 - 2025
5.3.2. Europe Hemostats Market, By Product Types, 2014 - 2025
5.3.3. Europe Hemostats Market, By Application, 2014 - 2025
5.3.4. Germany
5.3.4.1. Germany Hemostats Market, By Product Types, 2014 - 2025
5.3.4.2. Germany Hemostats Market, By Application, 2014 - 2025
5.3.5. UK
5.3.5.1. UK Hemostats Market, By Product Types, 2014 - 2025
5.3.5.2. UK Hemostats Market, By Application, 2014 - 2025
5.4. Asia Pacific
5.4.1. Asia Pacific Hemostats Market, 2014 - 2025
5.4.2. Asia Pacific Hemostats Market, By Product Types, 2014 - 2025
5.4.3. Asia Pacific Hemostats Market, By Application, 2014 - 2025
5.4.4. Australia
5.4.4.1. Australia Hemostats Market, By Product Types, 2014 - 2025
5.4.4.2. Australia Hemostats Market, By Application, 2014 - 2025
5.4.5. New Zealand
5.4.5.1. New Zealand Hemostats Market, By Product Types, 2014 -
2025
5.4.5.2. New Zealand Hemostats Market, By Application, 2014 -2025
5.4.5.3. New Zealand Hemostats Market, By End-Use, 2014 -2025
5.4.6. China
5.4.6.1. China Hemostats Market, By Product Types, 2014 - 2025
5.4.6.2. China Hemostats Market, By Application, 2014 - 2025
5.4.7. India
5.4.7.1. India Hemostats Market, By Product Types, 2014 - 2025
5.4.7.2. India Hemostats Market, By Application, 2014 - 2025
5.4.8. Japan
5.4.8.1. Japan Hemostats Market, By Product Types, 2014 - 2025
5.4.8.2. Japan Hemostats Market, By Application, 2014 - 2025
5.5. South America
5.5.1. South America Hemostats Market, 2014 - 2025
5.5.2. South America Hemostats Market, By Product Types, 2014 - 2025
5.5.3. South America Hemostats Market, By Application, 2014 - 2025
5.5.4. Brazil
5.5.4.1. Brazil Hemostats Market, By Product Types, 2014 - 2025
5.5.4.2. Brazil Hemostats Market, By Application, 2014 - 2025
5.5.5. Mexico
5.5.5.1. Mexico Hemostats Market, By Product Types, 2014 - 2025
5.5.5.2. Mexico Hemostats Market, By Application, 2014 - 2025
5.6. MEA
5.6.1. MEA Hemostats Market, 2014 - 2025
5.6.2. MEA Hemostats Market, By Product Types, 2014 - 2025
5.6.3. MEA Hemostats Market, By Application, 2014 - 2025
5.6.4. Saudi Arabia
5.6.4.1. Saudi Arabia Hemostats Market, By Product Types, 2014 - 2025
5.6.4.2. Saudi Arabia Hemostats Market, By Application, 2014 - 2025
5.6.5. Egypt
5.6.5.1. Egypt Hemostats Market, By Product Types, 2014 - 2025
5.6.5.2. Egypt Hemostats Market, By Application, 2014 - 2025


6. COMPETITIVE LANDSCAPE

6.1. CryoLife, Inc
6.1.1. Company overview
6.1.2. Financial performance
6.1.3. Product benchmarking
6.1.4. Strategic initiatives
6.2. Marine Polymer Technologies, Inc
6.2.1. Company overview
6.2.2. Financial performance
6.2.3. Product benchmarking
6.2.4. Strategic initiatives
6.3. Johnson & Johnson
6.3.1. Company overview
6.3.2. Financial performance
6.3.3. Product benchmarking
6.3.4. Strategic initiatives
6.4. C. R. Bard, Inc
6.4.1. Company overview
6.4.2. Financial performance
6.4.3. Product benchmarking
6.4.4. Strategic initiatives
6.5. Baxter
6.5.1. Company overview
6.5.2. Financial performance
6.5.3. Product benchmarking
6.5.4. Strategic initiatives
6.6. Integra Lifesciences Holdings Corporation
6.6.1. Company overview
6.6.2. Financial performance
6.6.3. Product benchmarking
6.6.4. Strategic initiatives
6.7. B Braun Melsungen AG
6.7.1. Company overview
6.7.2. Financial performance
6.7.3. Product benchmarking
6.7.4. Strategic initiatives
6.8. Vascular Solutions, Inc
6.8.1. Company overview
6.8.2. Financial performance
6.8.3. Product benchmarking
6.8.4. Strategic initiatives
6.9. Pfizer Inc
6.9.1. Company overview
6.9.2. Financial performance
6.9.3. Product benchmarking
6.9.4. Strategic initiatives

End of the report
Disclaimer.





Content are not available

Choose License Type